Sign In
Eli Lilly & Company (LLY)
SHARE
Email Confirmation
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME
Overview
News
People
Financials
Company Information
Dr. John C. Lechleiter, Ph.D., President/COO/Director/CEO
Lilly Corporate Center
Indianapolis, IN 46285
US
Map it 
Overview
The Company discovers, develops, manufactures and sells products in one segment of pharmaceutical products.
Press Releases
-
Spencer Crain Selected for Minority & Women-Owned Law Firm Honor Jan-06-2009, 08:15AM EST
-
Promedior Announces Appointment of Dominick Colangelo as Chief Executive Officer Jan-06-2009, 08:00AM EST
-
Zacks Industry Outlook Highlights: Pfizer, Bristol-Myers, Johnson & Johnson, Merck and Eli Lilly Jan-06-2009, 06:00AM EST
-
FDA Cardio Renal Advisory Committee to Review Daiichi Sankyo, Lilly Drug Prasugrel Dec-31-2008, 09:16AM EST
News From Around the Web
News
-
Final Glance: Pharmaceuticals companies (Boston Globe)Jan 08 2009
-
Early Glance: Pharmaceuticals companies (Boston Globe)Jan 08 2009
-
Your Once-in-a-Lifetime Investing Opportunity (Motley Fool)Jan 08 2009
-
Pharmaceuticals companies shares mixed at noon (Canadian Business Online)Jan 08 2009
-
Eli Lilly faces FDA delay on schizophrenia drug (Businessweek)Jan 08 2009
-
Pharmaceuticals companies shares down at the close of trading (Canadian Business Online)Jan 07 2009
-
Jan 07 2009
-
Eli Lilly Builds On Monday's Loss (RTTNews)Jan 06 2009
-
Sun Sets on Drug-Company Pens in Doctors' Offices (Wall Street Journal Health Blog)Jan 06 2009
-
Clinical Implications of the Overlapping Neurobiology of Pain and Depression (CME) (Modern Medicine)Jan 05 2009
Employees
Number of Employees: 40,600
Revenue per Employee: $426,246
Financials
Quarterly
Annual
| Income Statement | 10/2008 | 07/2008 | 04/2008 | 01/2008 |
|---|---|---|---|---|
| Sales | 1.16 Bil. | NA | 1.11 Bil. | 1.27 Bil. |
| Gross Operating Profit | 4.05 Bil. | 1.2 Bil. | 3.7 Bil. | 3.92 Bil. |
| Operating Income before D & A (EBITDA) | 1.45 Bil. | 1.2 Bil. | 1.27 Bil. | 1.21 Bil. |
| Total Income Before Interest Expenses (EBIT) | -214 Mil. | 1.2 Bil. | 1.06 Bil. | 1.14 Bil. |
| Total Net Income | -465.6 Mil. | 80.26 Mil. | 1.06 Bil. | 854.4 Mil. |
| Basic EPS, Total | -0.43 | 0.48 | 0.97 | 0.78 |
| Diluted EPS, Total | -0.43 | 0.46 | 0.97 | 0.78 |
| BALANCE STATEMENT | 10/2008 | 07/2008 | 04/2008 | 01/2008 |
|---|---|---|---|---|
| Cash and Equivalents | NA | NA | NA | NA |
| Total Assets | NA | NA | NA | NA |
| Total Liabilities | NA | NA | NA | NA |
| Total Capitalization | NA | NA | NA | NA |
| Cash Flow | 10/2008 | 07/2008 | 04/2008 | 01/2008 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | NA | NA | NA | NA |
| Net Cash From Investing Activities | NA | NA | NA | NA |
| Net Cash From Financing Activities | NA | NA | NA | NA |
| Net Change in Cash & Cash Equivalents | NA | NA | NA | NA |
| Income Statement | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Sales | 4.25 Bil. | 2.74 Bil. | 2.75 Bil. | 2.63 Bil. |
| Gross Operating Profit | 14.38 Bil. | 12.95 Bil. | 11.9 Bil. | 11.23 Bil. |
| Operating Income before D & A (EBITDA) | 4.8 Bil. | 4.93 Bil. | 4.38 Bil. | 4.26 Bil. |
| Total Income Before Interest Expenses (EBIT) | 3.89 Bil. | 3.66 Bil. | 2.82 Bil. | 2.99 Bil. |
| Total Net Income | 295.3 Bil. | 2.66 Bil. | 1.98 Bil. | 1.81 Bil. |
| Basic EPS, Total | 2.71 | 2.45 | 1.82 | 1.67 |
| Diluted EPS, Total | 2.71 | 2.45 | 1.81 | 1.66 |
| BALANCE STATEMENT | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Cash and Equivalents | NA | 3.11 Bil. | 3.01 Bil. | 5.37 Bil. |
| Total Assets | NA | 9.69 Bil. | 10.8 Bil. | 12.84 Bil. |
| Total Liabilities | NA | 5.09 Bil. | 5.72 Bil. | 7.59 Bil. |
| Total Capitalization | NA | 14.48 Bil. | 16.56 Bil. | 15.41 Bil. |
| Cash Flow | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | NA | 3.98 Bil. | 1.91 Bil. | 2.87 Bil. |
| Net Cash From Investing Activities | NA | 608.4 Mil. | -2.22 Bil. | -684.8 Mil. |
| Net Cash From Financing Activities | NA | -4.58 Bil. | -1.88 Bil. | 203.7 Mil. |
| Net Change in Cash & Cash Equivalents | NA | 102.6 Mil. | -2.36 Bil. | 2.61 Bil. |
Related Companies by Market Cap
Company Name
Price
Change
Market Cap
54.72 Bil.
63.75 Bil.
45.45 Bil.
30.81 Bil.
Company Profile Change Request
The data provided in our company profiles comes from third party information providers.- To request a change please click here
Also in Portfolio.com
Most Read
Most Emailed
Recently Commented
TOP 5
(Daily)
A smart take on the top stories shaping the business world.
Executives & Careers
(Tuesdays)
A weekly guide to the personalities and ideas that are transforming the business world.
Inside Portfolio.com
(Wednesdays)
Our roundup of the week's best from Portfolio.com.
Culture & Lifestyle
(Fridays)
A weekly guide to the best ways to spend your time - and money.
In This Issue
(Monthly)
Be the first to know when the latest issue of Condé Nast Portfolio magazine is online.
RSS Most Read
Mobile